22157.jpg
Europe Medical Cannabis Snapshot Report 2024: Germnay, UK, Poland, Czech Republic, Switzerland Market Sizes, Top Brands, Product Forms, Consumption Patterns, Product Origin, and Regulatory Landscapes
03 déc. 2024 04h27 HE | Research and Markets
Dublin, Dec. 03, 2024 (GLOBE NEWSWIRE) -- The "Europe Medical Cannabis Snapshot Bundle" report has been added to ResearchAndMarkets.com's offering. The Europe Medical Cannabis Snapshot Bundle...
22157.jpg
Global and US CBD Regulatory Database 2024: Essential Information About How CBD is Regulated in Key Markets to Ensure your Business Complies with All Legal Requirements
27 nov. 2024 04h13 HE | Research and Markets
Dublin, Nov. 27, 2024 (GLOBE NEWSWIRE) -- The "Global CBD Regulatory Database" database has been added to ResearchAndMarkets.com's offering. This database bundle provide essential information...
22157.jpg
Global and United States Medical and Recreational Cannabis Database 2024: Legal Status, Production and Licensing, Consumption and Prescription, Legal Proposals and Political Initiatives
27 nov. 2024 04h12 HE | Research and Markets
Dublin, Nov. 27, 2024 (GLOBE NEWSWIRE) -- The "Global Medical and Recreational Cannabis Database" database has been added to ResearchAndMarkets.com's offering. This dataset provides essential...
TilrayBrands_Logo_FullColor_RBG_Horiz-01.png
Tilray Medical Launches its First Commercial “Grown in Germany” Medical Cannabis Products Under its Newly Expanded Cultivation License
14 nov. 2024 07h00 HE | Tilray Brands, Inc.
Tilray Medical announced the launch of its first commercial German grown medical cannabis flowers from its Aphria RX GmbH (“Aphria RX”) facility.
TilrayBrands_Logo_FullColor_RBG_Horiz-01.png
Tilray Medical Announces Positive Results from Study on Oral Cannabis Extract for Chemotherapy-Induced Emesis
07 nov. 2024 07h00 HE | Tilray Brands, Inc.
This trial aimed to test the effectiveness of an oral cannabis extract in adults suffering from negative chemotherapy-induced side effects.
22157.jpg
International Directory of Medical Cannabis Companies 2024
04 oct. 2024 04h54 HE | Research and Markets
Dublin, Oct. 04, 2024 (GLOBE NEWSWIRE) -- The "International Directory of Medical Cannabis Companies 2024" directory has been added to ResearchAndMarkets.com's offering.The International Directory...
TilrayBrands_Logo_FullColor_RBG_Horiz-01.png
Tilray Medical Launches Redecan Cannabis Brand in Australia
18 sept. 2024 07h00 HE | Tilray Brands, Inc.
Tilray's EU-GMP Certified Redecan Cannabis Now Available in Australia with Medical Prescription.
IMG_9924
Organic Remedies Raises $15,000 for Speranza Animal Rescue
17 sept. 2024 08h15 HE | Organic Remedies
Organic Remedies proudly announced it has raised $15,000 for Speranza Animal Rescue during its month-long Dog Days of Summer campaign in August.
TilrayBrands_Logo_FullColor_RBG_Horiz-01.png
Tilray Medical Supports Scientific Study on Fibromyalgia With Positive Outcomes: Effectiveness of Cannabinoids Treatment in Pain Management and Other Fibromyalgia-Associated Symptoms
09 sept. 2024 07h00 HE | Tilray Brands, Inc.
LISBON, Portugal, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY) and a global leader in medical cannabis, empowering the...
22157.jpg
World Cannabis Market Report 2024: Examining Five Drivers Shaping Legal Cannabis
06 sept. 2024 05h22 HE | Research and Markets
Dublin, Sept. 06, 2024 (GLOBE NEWSWIRE) -- The "World Market for Cannabis" report has been added to ResearchAndMarkets.com's offering. Backed partly by existing legacy use, there is a broad-based...